EU quality system requirements for drugs and biologics
How Directive 2001/83/EC governs the manufacture and import of medicinal products in the EU, from manufacturing authorisation through to batch certification.
17 posts
How Directive 2001/83/EC governs the manufacture and import of medicinal products in the EU, from manufacturing authorisation through to batch certification.
What EU law requires of marketing authorisation holders after authorisation, from adverse reaction reporting and PSURs to additional monitoring.
How EU medicines reach the market: the centralised Union route, national authorisation, mutual recognition and decentralised procedures, with their timelines and evidence.
How Directive 2001/83/EC governs outer packaging, immediate packaging and package leaflet content for medicines in the EU, and what claims are barred.
How Directive 2001/83/EC sets the evidence for a marketing authorisation, covering full dossiers and the generic, biosimilar and well-established use routes.
How Regulation (EU) No 536/2014 governs clinical trials of medicinal products, from authorisation through the EU portal to informed consent.
What a manufacturer files under Regulation (EU) 2017/745: Annex II and III technical documentation, the route by class and how notified bodies review it.
How Regulation (EU) 2017/745 requires manufacturers to run a quality management system, from design through surveillance, and who must oversee it.
How Article 5(5) of the IVDR allows a health institution to make and use its own in vitro diagnostic, and the nine conditions attached.
How Regulation (EU) 2017/745 governs post-market surveillance, PSURs, vigilance reporting deadlines and field safety corrective actions for medical devices.
How Annex VIII of Regulation (EU) 2017/746 assigns in vitro diagnostics to classes A, B, C and D, and what each class determines.
How device class under Regulation (EU) 2017/745 sets the conformity assessment route, with the Annex IX, X and XI procedures and transitional deadlines.
How FDA classification and special controls compare with IVDR performance evaluation in the evidence a single in vitro diagnostic has to generate.
How Regulation (EU) 2017/745 governs device claims, label particulars, sterile packaging text and the content of instructions for use.
How Regulation (EU) 2017/745 sets the clinical evidence for a CE marked device, covering clinical evaluation, investigations, equivalence and PMCF.
How Regulation (EU) 2017/745 governs clinical investigations of medical devices, which studies it covers and when authorisation or notification is needed.
How Annex VIII of Regulation (EU) 2017/745 assigns medical devices to class I, IIa, IIb or III, and the rules that decide which class applies.